Skip to content

13F-HR filed by MSD Partners, L.P.

MSD Partners, L.P. filed this 13F-HR for the quarter ended 2017-12-31, filed 2018-02-14, with 24 holding rows worth $1,926,852,000.

Accession
0000950123-18-002421
Filed
2018-02-14
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q4 2017

A holdings report, 24 entries on the cover page, a total value of $1,926,852,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $1,926,852,000 with VALUE read as thousands by filing date, 13F file number 028-14878. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
SPY78462F103SHS5,000,000$1,334,300,000thousands by filing datecall
ALTABA INC021346101COM3,408,587$238,090,000thousands by filing date
COTY INC222070203COM CL A7,143,872$142,092,000thousands by filing date
HALOZYME THERAPEUTICS INC COM40637H109Stock2,245,000$45,484,000thousands by filing date
NATIONAL GEN HLDGS CORP636220303COM1,162,500$22,832,000thousands by filing date
HRG GROUP INC COM40434J100Stock1,022,878$17,338,000thousands by filing date
NOVAGOLD RESOURCES INC66987E206COM NEW4,234,129$16,640,000thousands by filing date
STEALTHGAS INCY81669106COM3,708,819$16,170,000thousands by filing date
TRIBUNE COMPANY896047503COMMON365,000$15,502,000thousands by filing date
BLUEKNIGHT ENERGY PARTNERS LP09625U109PREFERRED2,794,826$14,254,000thousands by filing date
ZIOPHARM ONCOLOGY INC98973P101COM3,410,500$14,119,000thousands by filing date
iShares MSCI Japan ETF46434G822SHS204,000$12,226,000thousands by filing datecall
BMC STK HLDGS INC05591B109COM482,088$12,197,000thousands by filing date
MARTEN TRANSPORT LTD573075108COM500,000$10,150,000thousands by filing date
JPMorgan Chase & Co46625H100COM75,000$8,020,000thousands by filing date
COOPER STANDARD HOLDING21676P103COMMON STOCK19,879$2,435,000thousands by filing date
SYNTHETIC BIOLOGICS INC87164U102COM4,118,402$2,092,000thousands by filing date
EGALET CORP28226B104COM1,040,009$1,040,000thousands by filing date
INTELLIA THERAPEUTICS INC45826J105COM30,000$577,000thousands by filing date
FIBROCELL SCIENCE INC315721308COM PAR692,960$443,000thousands by filing date
ORAGENICS INC684023203COM NEW1,725,000$405,000thousands by filing date
NABRIVA THERAPEUTICS PLCG63637105SHS50,000$299,000thousands by filing date
ALPS ETF TR00162Q866ALERIAN MLP12,200$132,000thousands by filing datecall
AMPLIPHI BIOSCIENCES CORP03211P301COM PAR15,011$15,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000950123-18-002421this filing2018-02-14acceptance time not in the bulk data set